HLI Stock News & Analysis | Latest Updates

Human Longevity, Inc. Expands Pancreatic Cancer Prevention Commitment with $1 Million Pledge for Qualified Members

SOUTH SAN FRANCISCO, Calif., June 17, 2025 /PRNewswire/ -- Human Longevity, Inc. (HLI), a global leader in precision medicine and proactive health, today announced an expansion of its $1 million pledge initiative—this time targeting late-stage pancreatic cancer. Building on the success of...

June 17, 2025Cancer

HLI News

Human Longevity, Inc. Expands Pancreatic Cancer Prevention Commitment with $1 Million Pledge for Qualified Members

Here's How Much You Would Have Made Owning Houlihan Lokey Stock In The Last 5 Years

Price Over Earnings Overview: Houlihan Lokey

Here's How Much You Would Have Made Owning Houlihan Lokey Stock In The Last 5 Years

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Keefe, Bruyette & Woods Maintains Market Perform on Houlihan Lokey, Raises Price Target to $185

Wells Fargo Maintains Overweight on Houlihan Lokey, Raises Price Target to $185

Houlihan Lokey Q4 Adj. EPS $1.96 Beats $1.62 Estimate, Sales $666.42M Beat $629.32M Estimate

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Wells Fargo Maintains Overweight on Houlihan Lokey, Lowers Price Target to $170

10 Analysts Have This To Say About Houlihan Lokey

Morgan Stanley Maintains Overweight on Houlihan Lokey, Lowers Price Target to $156

What's Driving the Market Sentiment Around Houlihan Lokey?

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Morgan Stanley Upgrades Houlihan Lokey to Overweight, Lowers Price Target to $190

Assessing Houlihan Lokey: Insights From 10 Financial Analysts

Wells Fargo Upgrades Houlihan Lokey to Overweight, Lowers Price Target to $179

Here's How Much $100 Invested In Houlihan Lokey 5 Years Ago Would Be Worth Today

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Wells Fargo Maintains Underweight on Houlihan Lokey, Lowers Price Target to $178

Forecasting The Future: 4 Analyst Projections For Houlihan Lokey

Keefe, Bruyette & Woods Maintains Market Perform on Houlihan Lokey, Lowers Price Target to $170

Looking Into Houlihan Lokey's Recent Short Interest

Keefe, Bruyette & Woods Maintains Market Perform on Houlihan Lokey, Raises Price Target to $172

Peering Into Houlihan Lokey's Recent Short Interest

(HLI) - Analyzing Houlihan Lokey's Short Interest

Houlihan Lokey Expands Capital Markets Team With Senior European Hire